233691481	233691481	CD	B-NP	O
|	|	NN	I-NP	O
SCSH	SCSH	NN	I-NP	O
|	|	NN	I-NP	O
54533817	54533817	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6842980	6842980	CD	B-NP	O
|	|	CC	I-NP	O
10/3/2005	10/3/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PERFORATED	PERFORATED	NNP	I-NP	I-protein
DUODUNUM	DUODUNUM	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/3/2005	10/3/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/10/2006	5/10/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
CARAVALHO	CARAVALHO	NN	B-NP	O
,	,	,	O	O
PARIS	PARIS	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Enterobacter	Enterobacter	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

MRSA	MRSA	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
failure	failure	NN	I-NP	O
requiring	require	VBG	B-VP	O
tracheostomy	tracheostomy	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
68-year-old	68-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
a	a	DT	B-NP	O
perforated	perforated	JJ	I-NP	O
duodenal	duodenal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
repaired	repair	VBN	B-VP	O
on	on	IN	B-PP	O
8/13/05	8/13/05	CD	B-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
course	course	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
failure	failure	NN	I-NP	O
requiring	require	VBG	B-VP	O
mechanical	mechanical	JJ	B-NP	O
ventilation	ventilation	NN	I-NP	O
and	and	CC	I-NP	O
hypotension	hypotension	NN	I-NP	O
that	that	WDT	B-NP	O
required	require	VBD	B-VP	O
pressor	pressor	NN	B-NP	O
support	support	NN	I-NP	O
with	with	IN	B-PP	O
Neo-Synephrine	Neo-Synephrine	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diureses	diures	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
and	and	CC	O	O
on	on	IN	B-PP	O
5/29/05	5/29/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Erverv	Erverv	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
facemask	facemask	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/29/05	4/29/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
for	for	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
manipulation	manipulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
tubes	tube	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
desaturate	desaturate	VB	I-VP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
intubation	intubation	NN	B-NP	O
.	.	.	O	O

Bronchoscopy	Bronchoscopy	NNP	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
copious	copious	JJ	B-NP	O
secretions	secretion	NNS	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
on	on	IN	B-PP	O
4/29/05	4/29/05	CD	B-NP	O
showed	show	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
and	and	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diastolic	Diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Osteoarthritis	Osteoarthritis	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Peptic	Peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
gram	gram	NN	I-NP	O
patch	patch	NN	I-NP	O
for	for	IN	B-PP	O
perforated	perforated	JJ	B-NP	O
duodenal	duodenal	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
on	on	IN	B-PP	O
8/13/05	8/13/05	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Cervical	Cervical	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
TRANSFER	TRANSFER	NN	B-NP	O
TO	TO	TO	B-PP	O
THE	THE	DT	B-NP	O
CCU	CCU	NN	I-NP	O
:	:	:	O	O
Fentanyl	Fentanyl	NN	B-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
versed	verse	VBN	B-VP	O
drip	drip	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
6	6	CD	B-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

VITALS	VITALS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
TRANSFER	TRANSFER	NN	B-NP	O
TO	TO	TO	B-PP	O
THE	THE	DT	B-NP	O
CCU	CCU	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
102	102	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
100-113	100-113	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
86-125/39	86-125/39	CD	B-NP	O
-50	-50	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ventilated	ventilate	VBN	I-VP	O
on	on	IN	B-PP	O
assist	assist	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
tidal	tidal	JJ	B-NP	O
volume	volume	NN	I-NP	O
400	400	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
,	,	,	O	O
overbreathing	overbreathe	VBG	B-VP	O
at	at	IN	B-PP	O
27	27	CD	B-NP	O
,	,	,	O	O
PEEP	PEEP	NN	B-NP	B-protein
of	of	IN	B-PP	O
10	10	CD	B-NP	O
with	with	IN	B-PP	O
PIP	PIP	NN	B-NP	B-protein
of	of	IN	B-PP	O
33	33	CD	B-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
FiO2	FiO2	NN	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
and	and	CC	O	O
only	only	RB	B-ADJP	O
mildly	mildly	RB	I-ADJP	O
responsive	responsive	JJ	I-ADJP	O
to	to	TO	B-PP	O
stimuli	stimulus	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
S4	S4	NN	I-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
murmur	murmur	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	O	O
assessable	assessable	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
exam	exam	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
grimaces	grimace	VBZ	B-VP	O
with	with	IN	B-PP	O
deep	deep	JJ	B-NP	O
palpation	palpation	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
quadrant	quadrant	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
rash	rash	NN	B-NP	O
and	and	CC	O	O
good	good	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	B-protein
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
13.3	13.3	NN	B-NP	B-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
30.8	30.8	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	B-protein
141	141	CD	I-NP	I-protein
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.5	4.5	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	B-protein
131	131	CD	I-NP	I-protein
.	.	.	O	O

PTT	PTT	NN	B-NP	O
was	be	VBD	B-VP	O
32.6	32.6	CD	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.4	1.4	CD	I-NP	I-protein
.	.	.	O	O

LFTs	LFT	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
total	total	JJ	I-NP	O
bilirubin	bilirubin	NN	I-NP	O
at	at	IN	B-PP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
27	27	CD	B-NP	O
.	.	.	O	O

MB	MB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
0.4	0.4	CD	B-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
0.22	0.22	CD	B-NP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
PERFORMED	PERFORMED	VBD	B-VP	O
DURING	DURING	NN	B-NP	O
THIS	THIS	NN	I-NP	O
HOSPITALIZATION	HOSPITALIZATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
4/29/05	4/29/05	CD	B-NP	O
that	that	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
left	left	JJ	B-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
and	and	CC	O	O
lingular	lingular	JJ	B-NP	O
branch	branch	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
6/21/06	6/21/06	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
segmental	segmental	JJ	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
basal	basal	JJ	I-NP	O
and	and	CC	I-NP	O
lateral	lateral	JJ	I-NP	O
basal	basal	JJ	I-NP	O
segments	segment	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
,	,	,	O	O
minimal	minimal	JJ	B-NP	O
left-sided	left-sided	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
slight	slight	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
opacities	opacity	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
improving	improve	VBG	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
4/29/05	4/29/05	CD	B-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
intraperitoneal	intraperitoneal	JJ	I-NP	O
gas	gas	NN	I-NP	O
or	or	CC	I-NP	O
extravasation	extravasation	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
to	to	TO	B-VP	O
suggest	suggest	VB	I-VP	O
persistent	persistent	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
perforation	perforation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
to	to	TO	I-NP	O
moderate	moderate	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
localized	localized	JJ	I-NP	O
2.5	2.5	CD	I-NP	O
cm	cm	NN	I-NP	O
phlegmonous	phlegmonous	JJ	I-NP	O
area	area	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
pericolic	pericolic	JJ	I-NP	O
gutter	gutter	NN	I-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
amenable	amenable	JJ	I-ADJP	O
to	to	TO	B-PP	O
percutaneous	percutaneous	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
abdominal	abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
9/6/06	9/6/06	CD	B-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
splenic	splenic	JJ	B-NP	O
subcapsular	subcapsular	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
and	and	CC	O	O
enlarged	enlarge	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
ovaries	ovary	NNS	I-NP	O
.	.	.	O	O

Transvaginal	Transvaginal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
on	on	IN	B-PP	O
8/26/06	8/26/06	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
mildly	mildly	RB	B-NP	O
enlarged	enlarged	JJ	I-NP	O
and	and	CC	I-NP	O
lobular	lobular	JJ	I-NP	O
right	right	JJ	I-NP	O
ovary	ovary	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
x	x	SYM	I-NP	O
3	3	CD	I-NP	O
x	x	SYM	I-NP	O
2.7	2.7	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
68-year-old	68-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
duodenal	duodenal	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
on	on	IN	B-PP	O
9/29/06	9/29/06	CD	B-NP	O
,	,	,	O	O
requiring	require	VBG	B-VP	O
gram	gram	NN	B-NP	O
patch	patch	NN	I-NP	O
repair	repair	NN	I-NP	O
,	,	,	O	O
complicated	complicate	VBN	B-VP	O
postoperatively	postoperatively	RB	B-ADVP	O
by	by	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
,	,	,	O	O
Enterobacter	Enterobacter	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
coag-negative	coag-negative	JJ	B-NP	O
Staph	Staph	NNP	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
ISSUE	ISSUE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Enterobacter	Enterobacter	NNP	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
imipenem	imipenem	NN	B-NP	O
for	for	IN	B-PP	O
Enterobacter	Enterobacter	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
CT	CT	NN	I-NP	B-protein
on	on	IN	B-PP	O
10/22/05	10/22/05	CD	B-NP	O
showed	show	VBD	B-VP	O
resolving	resolve	VBG	I-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
culture	culture	NN	I-NP	O
from	from	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
,	,	,	O	O
revealed	reveal	VBD	B-VP	O
Enterobacter	Enterobacter	NNP	B-NP	O
and	and	CC	I-NP	O
MRSA	MRSA	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
sputum	sputum	NN	I-NP	O
cultures	culture	NNS	I-NP	O
through	through	IN	B-PP	O
7/21/06	7/21/06	CD	B-NP	O
showed	show	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
Enterobacter	Enterobacter	NNP	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
persistently	persistently	RB	B-ADVP	O
febrile	febrile	NN	B-NP	O
and	and	CC	I-NP	O
repeat	repeat	NN	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
new	new	JJ	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
infiltrate	infiltrate	NN	B-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
ground	ground	NN	I-NP	O
glass	glass	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
imipenem	imipenem	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
linezolid	linezolid	NN	B-NP	O
per	per	IN	B-PP	O
recommendation	recommendation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
consult	consult	NN	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
imipenem	imipenem	NN	B-NP	O
on	on	IN	B-PP	O
4/5/06	4/5/06	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
linezolid	linezolid	NN	B-NP	O
on	on	IN	B-PP	O
1/1/06	1/1/06	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
1/10/06	1/10/06	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Pseudomonas	Pseudomonas	NNP	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
7/21/06	7/21/06	CD	B-NP	O
that	that	WDT	B-NP	O
grew	grow	VBD	B-VP	O
100	100	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
colonies	colony	NNS	I-NP	O
of	of	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
on	on	IN	B-PP	O
10/6/06	10/6/06	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
on	on	IN	B-PP	O
7/25/06	7/25/06	CD	B-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
microbiologic	microbiologic	JJ	B-NP	O
susceptibilities	susceptibility	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
on	on	IN	B-PP	O
4/5/06	4/5/06	CD	B-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
Enterococcus	Enterococcus	NNP	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
10/19/06	10/19/06	CD	B-NP	O
grew	grow	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
susceptible	susceptible	JJ	I-NP	O
Enterococcus	Enterococcus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
linezolid	linezolid	NN	B-NP	O
.	.	.	O	O

D.	D.	NNP	B-NP	O
Candidal	Candidal	NNP	I-NP	O
intertrigo	intertrigo	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
topical	topical	JJ	B-NP	O
antifungals	antifungal	NNS	I-NP	O
with	with	IN	B-PP	O
failure	failure	NN	B-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
candidal	candidal	JJ	B-NP	O
skin	skin	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
fluconazole	fluconazole	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
on	on	IN	B-PP	O
8/26/06	8/26/06	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
prolonged	prolong	VBN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ventilator	ventilator	NN	B-NP	O
dependence	dependence	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
6/26/05	6/26/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	I-VP	O
trach	trach	VB	I-VP	O
collar	collar	NN	B-NP	O
on	on	IN	B-PP	O
7/25/06	7/25/06	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
trach	trach	NN	I-NP	O
collar	collar	NN	I-NP	O
was	be	VBD	B-VP	O
capped	cap	VBN	I-VP	O
on	on	IN	B-PP	O
1/10/06	1/10/06	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
tolerating	tolerate	VBG	I-VP	O
oxygen	oxygen	NN	B-NP	O
via	via	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
since	since	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
A.	A.	NN	B-NP	O
Pulmonary	Pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
left	leave	VBN	I-VP	O
upper	upper	JJ	B-NP	O
lobe	lobe	NN	I-NP	O
and	and	CC	O	O
lingular	lingular	JJ	B-NP	O
branch	branch	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
emboli	embolus	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
discussed	discuss	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
8/7/06	8/7/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
on	on	IN	B-PP	O
7/23/06	7/23/06	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
bridge	bridge	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
until	until	IN	B-PP	O
4/5/06	4/5/06	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
is	be	VBZ	B-VP	O
3	3	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
2.7	2.7	CD	B-NP	O
on	on	IN	B-PP	O
1/1/06	1/1/06	CD	B-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
and	and	CC	I-VP	O
adjust	adjust	VB	I-VP	O
dose	dose	NN	B-NP	O
accordingly	accordingly	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
DVT	DVT	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Non-invasive	Non-invasive	JJ	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Iron	Iron	NNP	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
iron	iron	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
on	on	IN	B-PP	O
8/6/06	8/6/06	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
TIBC	TIBC	NN	I-NP	B-protein
of	of	IN	B-PP	O
181	181	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ferritin	ferritin	NN	B-NP	O
of	of	IN	B-PP	O
828	828	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transfusion	transfusion	NN	I-NP	O
goal	goal	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
27	27	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
4/13/05	4/13/05	CD	B-NP	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
normal	normal	JJ	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
akinesis	akinesis	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
global	global	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
right	right	JJ	B-NP	O
atrium	atrium	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
valves	valve	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
small	small	JJ	B-NP	O
circumscribed	circumscribe	VBN	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
successfully	successfully	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
down	down	RP	B-PRT	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	B-ADVP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
concerns	concern	NNS	B-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diureses	diures	NNS	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
weights	weight	NNS	B-NP	O
and	and	CC	O	O
dose	dose	NN	B-NP	O
torsemide	torsemide	NN	I-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
fever	fever	NN	B-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
was	be	VBD	B-VP	O
87-104	87-104	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Gynecologic	Gynecologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
bilateral	bilateral	JJ	B-NP	O
enlarged	enlarged	JJ	I-NP	O
ovaries	ovary	NNS	I-NP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
confirmed	confirm	VBN	B-VP	O
by	by	IN	B-PP	O
transvaginal	transvaginal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
on	on	IN	B-PP	O
8/26/06	8/26/06	CD	B-NP	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
enlarged	enlarged	JJ	I-NP	O
and	and	CC	I-NP	O
lobular	lobular	JJ	I-NP	O
right	right	JJ	I-NP	O
ovary	ovary	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
x	x	SYM	I-NP	O
3	3	CD	I-NP	O
x	x	SYM	I-NP	O
2.7	2.7	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
enlarged	enlarged	JJ	B-NP	O
ovary	ovary	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
comparison	comparison	NN	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
with	with	IN	B-PP	O
prior	prior	JJ	B-NP	O
pelvic	pelvic	JJ	I-NP	O
ultrasounds	ultrasound	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Recommended	Recommend	VBN	B-NP	O
further	further	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
evaluations	evaluation	NNS	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
ovarian	ovarian	JJ	B-NP	O
malignancy	malignancy	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
on	on	IN	B-PP	O
8/26/06	8/26/06	CD	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
of	of	IN	B-PP	O
Jevity	Jevity	NN	B-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
fiber	fiber	NN	I-NP	O
per	per	IN	B-PP	O
recommendations	recommendation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nutrition	nutrition	NN	I-NP	O
consult	consult	NN	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
continuing	continue	VBG	I-VP	O
the	the	DT	B-NP	O
free	free	JJ	I-NP	O
water	water	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
hypernatremia	hypernatremia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
pill	pill	NN	I-NP	O
dysphagia	dysphagia	NN	I-NP	O
and	and	CC	I-NP	O
esophagogram	esophagogram	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
mild-to-moderate	mild-to-moderate	JJ	B-NP	O
esophageal	esophageal	JJ	I-NP	O
dysmotility	dysmotility	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Endocrine	Endocrine	JJ	I-NP	O
consult	consult	NN	I-NP	O
team	team	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
for	for	IN	B-PP	O
monitoring	monitoring	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
tendency	tendency	NN	I-NP	O
to	to	TO	B-VP	O
become	become	VB	I-VP	O
hypoglycemic	hypoglycemic	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
tube	tube	NN	I-NP	O
feeds	feed	NNS	I-NP	O
are	be	VBP	B-VP	O
turned	turn	VBN	I-VP	O
off	off	RP	B-PRT	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
glucose	glucose	NN	B-NP	B-protein
fingersticks	fingerstick	NNS	I-NP	I-protein
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
We	We	PRP	B-NP	O
added	add	VBD	B-VP	O
Zyprexa	Zyprexa	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
and	and	CC	O	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
or	or	CC	I-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
have	have	VBP	B-VP	O
added	add	VBN	I-VP	O
Klonopin	Klonopin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
BUN	BUN	NN	I-NP	O
to	to	TO	B-PP	O
creatinine	creatinine	NN	B-NP	O
ratio	ratio	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
held	hold	VBN	I-VP	O
all	all	DT	B-NP	O
diuretic	diuretic	JJ	I-NP	O
agents	agent	NNS	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
constipated	constipate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Colace	Colace	NN	B-NP	O
and	and	CC	I-NP	O
senna	senna	NN	I-NP	O
with	with	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
lactulose	lactulose	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
disimpacted	disimpacte	VBN	I-VP	O
1/10/06	1/10/06	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
pill	pill	NN	I-NP	O
dysphagia	dysphagia	NN	I-NP	O
as	as	IN	B-SBAR	O
discussed	discuss	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
seen	see	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Dermatology	Dermatology	NNP	I-NP	O
consult	consult	NN	I-NP	O
service	service	NN	I-NP	O
on	on	IN	B-PP	O
4/5/06	4/5/06	CD	B-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
blanching	blanch	VBG	I-NP	O
erythematous	erythematous	JJ	I-NP	O
rash	rash	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
mid	mid	NN	I-NP	O
back	back	RB	B-ADVP	O
,	,	,	O	O
buttocks	buttock	NNS	B-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
thighs	thigh	NNS	I-NP	O
,	,	,	O	O
groin	groin	NN	B-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
around	around	IN	B-PP	O
her	her	PRP$	B-NP	O
pannus	pannus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Dermatology	Dermatology	NNP	I-NP	O
consult	consult	NN	I-NP	O
team	team	NN	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
drug	drug	NN	I-NP	O
hypersensitivity	hypersensitivity	NN	I-NP	O
eruption	eruption	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
timing	timing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rash	rash	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
,	,	,	O	O
it	it	PRP	B-NP	O
makes	make	VBZ	B-VP	O
it	it	PRP	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
offending	offend	VBG	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
likely	likely	JJ	B-NP	O
offenders	offender	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discontinued	discontinue	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
courses	course	NNS	I-NP	O
were	be	VBD	B-VP	O
completed	complete	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
rash	rash	NN	I-NP	O
is	be	VBZ	B-VP	O
fairly	fairly	RB	I-VP	O
limited	limit	VBN	I-VP	O
and	and	CC	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
improving	improve	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	JJ	B-NP	O
clobetasol	clobetasol	NN	I-NP	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
cream	cream	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
effected	effect	VBN	I-NP	O
areas	area	NNS	I-NP	O
with	with	IN	B-PP	O
pramoxine	pramoxine	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
lotion	lotion	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Sarna	Sarna	NNP	B-NP	O
lotion	lotion	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pruritus	pruritus	NN	B-NP	O
.	.	.	O	O

Okay	Okay	NN	B-NP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
rash	rash	NN	I-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
satisfactory	satisfactory	JJ	B-NP	O
condition	condition	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
laboratories	laboratory	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
135	135	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.8	3.8	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
39	39	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
80	80	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.7	0.7	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mildly	mildly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
alkaline	alkaline	JJ	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
at	at	IN	B-PP	O
134	134	CD	B-NP	O
.	.	.	O	O

Calcium	Calcium	NNP	B-NP	O
is	be	VBZ	B-VP	O
9.5	9.5	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.6	2.6	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
17.5	17.5	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
differential	differential	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
to	to	TO	B-PP	O
28.2	28.2	CD	B-NP	O
and	and	CC	O	O
stable	stable	JJ	B-NP	O
,	,	,	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
471	471	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
and	and	CC	O	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
low-grade	low-grade	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
discussed	discuss	VBN	B-VP	O
above	above	IN	B-PP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
2.7	2.7	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
and	and	CC	I-VP	O
adjust	adjust	VB	I-VP	O
Coumadin	Coumadin	NN	B-NP	O
accordingly	accordingly	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Medications	Medication	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
include	include	VBP	B-VP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
500-1000	500-1000	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
NG	NG	NN	B-NP	B-protein
tube	tube	NN	I-NP	I-protein
every	every	DT	B-NP	I-protein
four	four	CD	I-NP	I-protein
hours	hour	NNS	I-NP	I-protein
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
temperature	temperature	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
not	not	RB	O	O
to	to	TO	B-VP	O
exceed	exceed	VB	I-VP	O
4	4	CD	B-NP	O
g	g	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
Klonopin	Klonopin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
NG	NG	NN	B-NP	O
tube	tube	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
oversedated	oversedate	VBN	B-VP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
patch	patch	NN	I-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
topically	topically	RB	B-NP	O
every	every	DT	I-NP	O
72	72	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
fluconazole	fluconazole	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
completed	complete	VBN	I-VP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
13	13	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhaler	NN	I-NP	O
,	,	,	O	O
eight	eight	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	RB	B-NP	O
four	four	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
per	per	IN	B-PP	O
NG	NG	NN	B-NP	O
tube	tube	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
or	or	CC	O	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
two	two	CD	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
artificial	artificial	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
one	one	CD	B-NP	O
bottle	bottle	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
dry	dry	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
,	,	,	O	O
pramoxine	pramoxine	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
topical	topical	JJ	I-NP	O
three	three	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
drug	drug	NN	B-NP	O
hypersensitivity	hypersensitivity	NN	I-NP	O
rash	rash	NN	I-NP	O
on	on	IN	B-PP	O
mid	mid	NN	B-NP	O
back	back	RB	B-ADVP	O
,	,	,	O	O
buttocks	buttock	NNS	B-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
thighs	thigh	NNS	I-NP	O
,	,	,	O	O
groin	groin	NN	B-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
around	around	IN	B-PP	O
pannus	pannus	NN	B-NP	O
,	,	,	O	O
Sarna	Sarna	NNP	B-NP	O
topically	topically	RB	B-VP	O
applied	apply	VBD	I-VP	O
once	once	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
itching	itch	VBG	B-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
,	,	,	O	O
ocean	ocean	JJ	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
5	5	CD	I-NP	O
mL	mL	NN	I-NP	O
per	per	IN	B-PP	O
NG	NG	NN	B-NP	O
tube	tube	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Clobetazole	Clobetazole	NN	B-NP	O
0.05	0.05	CD	I-NP	O
%	%	NN	I-NP	O
cream	cream	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
drug	drug	NN	B-NP	O
hypersensitivity	hypersensitivity	NN	I-NP	O
,	,	,	O	O
drug	drug	NN	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
midback	midback	NN	B-NP	O
,	,	,	O	O
buttocks	buttock	NNS	B-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
thighs	thigh	NNS	I-NP	O
,	,	,	O	O
groin	groin	NN	B-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
round	round	JJ	B-NP	O
pannus	pannus	NN	I-NP	O
,	,	,	O	O
Zyprexa	Zyprexa	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topically	topically	RB	B-ADVP	O
twice	twice	RB	I-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
eight	eight	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
needed	need	VBD	B-VP	O
every	every	DT	B-NP	O
two	two	CD	I-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
Caltrate	Caltrate	NN	B-NP	O
plus	plus	CC	O	O
D	D	NN	B-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
52	52	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Zydis	Zydis	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
G-tube	G-tube	NNP	I-NP	O
daily	daily	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
XenoDerm	XenoDerm	NN	B-NP	O
topically	topically	RB	B-VP	O
applied	apply	VBD	I-VP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
to	to	TO	B-VP	O
bottom	bottom	VB	I-VP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
oral	oral	JJ	I-NP	O
liquid	liquid	NN	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
G-tube	G-tube	JJ	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
5	5	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-6579400	1-6579400	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MARROQUIN	MARROQUIN	NNP	B-NP	O
,	,	,	O	O
CORTEZ	CORTEZ	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BARTUCCA	BARTUCCA	NNP	B-NP	O
,	,	,	O	O
WILL	WILL	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9481124	9481124	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/1/06	1/1/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/1/06	1/1/06	CD	B-NP	O

